Neuro-Kinesis Corp. (NKC) has submitted an Application for Institutional Animal Care and Use Committee Approval (IACUC) for its upcoming animal studies for validation of the Huygens™ – Proteus™ Robotic Arm Surgical Platform. An agreement has been signed with the Technion Institute in Israel to begin the animal study validation of NKC’s surgical platform in Q1 2023. The platform includes the Huygens™ Catheter, the Lorentz™ Active Sheath, and the Proteus™ Robotic Arm which have been in development over the last several years.